Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ascendis Pharma A/S

173.15
+0.09000.05%
Post-market: 173.150.00000.00%17:49 EDT
Volume:484.69K
Turnover:84.32M
Market Cap:10.45B
PE:-27.51
High:177.06
Open:175.85
Low:172.00
Close:173.06
Loading ...

Is Ascendis Pharma A/S (ASND) the Best Growth Stock to Buy According to Billionaires?

Insider Monkey
·
15 Apr

High Growth Tech Stocks In US With Potential For Expansion

Simply Wall St.
·
15 Apr

Ascendis Pharma (ASND) Receives a Hold from Morgan Stanley

TIPRANKS
·
14 Apr

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

MT Newswires Live
·
09 Apr

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading

MT Newswires Live
·
07 Apr

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading

MT Newswires Live
·
01 Apr

Ascendis Submits U.S. NDA For Transcon CNP (Navepegritide) For The Treatment Of Children With Achondroplasia

Reuters
·
01 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading

MT Newswires Live
·
25 Mar

European Equities Traded in the US as American Depositary Receipts Track Lower in Wednesday Trading

MT Newswires Live
·
19 Mar

Ascendis Pharma Is Maintained at Overweight by JP Morgan

Dow Jones
·
18 Mar

European Equities Traded in the US as American Depositary Receipts Track Higher in Monday Trading

MT Newswires Live
·
17 Mar

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading

MT Newswires Live
·
13 Mar

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Up Slightly for Week

MT Newswires Live
·
08 Mar

TD Cowen Sticks to Its Buy Rating for Ascendis Pharma (ASND)

TIPRANKS
·
05 Mar

Exploring US High Growth Tech Stocks In March 2025

Simply Wall St.
·
04 Mar

Ascendis Pharma (ASND) Receives a Hold from Morgan Stanley

TIPRANKS
·
03 Mar

Ascendis Pharma Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
25 Feb

Morgan Stanley Sticks to Their Hold Rating for Ascendis Pharma (ASND)

TIPRANKS
·
24 Feb

Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Medtronic (MDT) and Tyra Bioscience (TYRA)

TIPRANKS
·
19 Feb

European Equities Traded in the US as American Depositary Receipts Rise Sharply in Tuesday Trading

MT Newswires Live
·
19 Feb